Review



integrin α6β4  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems integrin α6β4
    Integrin α6β4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/integrin α6β4/product/R&D Systems
    Average 94 stars, based on 9 article reviews
    integrin α6β4 - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    94
    Sino Biological integrin α6β4
    Integrin α6β4, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/integrin α6β4/product/Sino Biological
    Average 94 stars, based on 1 article reviews
    integrin α6β4 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    R&D Systems integrin α6β4
    Integrin α6β4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/integrin α6β4/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    integrin α6β4 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Hausser Scientific phenotypic spectrum of epidermolysis bullosa associated with α6β4 integrin mutations
    Phenotypic Spectrum Of Epidermolysis Bullosa Associated With α6β4 Integrin Mutations, supplied by Hausser Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phenotypic spectrum of epidermolysis bullosa associated with α6β4 integrin mutations/product/Hausser Scientific
    Average 90 stars, based on 1 article reviews
    phenotypic spectrum of epidermolysis bullosa associated with α6β4 integrin mutations - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson mouse anti-integrin α6β4
    Mouse Anti Integrin α6β4, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-integrin α6β4/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    mouse anti-integrin α6β4 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Hiran Orgochem α6β4 integrin
    α6β4 Integrin, supplied by Hiran Orgochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/α6β4 integrin/product/Hiran Orgochem
    Average 90 stars, based on 1 article reviews
    α6β4 integrin - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Sino Biological purified integrin α6β4
    Purified Integrin α6β4, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/purified integrin α6β4/product/Sino Biological
    Average 90 stars, based on 1 article reviews
    purified integrin α6β4 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Merck KGaA mabs directed against the α5β1, αvβ3, αvβ5, or α6β4 integrins antibody
    Blockade of Tat entry in IC-HUVEC by antibodies directed against the α5β1, αvβ3, and/or αvβ5 integrin. In ( A ), activated HUVEC were suspended and then incubated for 2 h with 5 μg/mL of monoclonal antibodies (mAb) directed against CD31 (upper left panel), α5β1 (upper right panel), or αvβ3 (lower left panel), or with anti-α5β1 and anti-αvβ3 mAb, combined together at 5 μg/mL each (lower right panel). In ( B ), IC-HUVEC were suspended and then incubated for 2 h with 5 μg/mL of <t>anti-α6β4</t> mAb (upper left panel), or with 5 μg/mL of anti-αvβ5 mAb, alone (upper right panel) or combined with anti-α5β1 and anti-αvβ3 mAb (lower panel). For both ( A , B ), IC-HUVEC incubated with Ab dilution buffer (PBS-0.1% BSA) were employed as controls (Nil). After incubation, IC-HUVEC was exposed for 10 min to biologically active Tat (1–1000 ng/mL) or its buffer. Intracellular Tat content was assayed by intracellular staining and flow cytometry as described. Results are expressed as the percentage of positive cells as compared to isotype-stained samples and non-permeabilized cells. Box-plot data obtained from three to four independent experiments and analyzed by the Mann–Whitney test are shown. Dots indicate individual measures. Orange plots refer to IC-HUVEC incubated with the said mAbs; blue plots refer to control IC-HUVEC.
    Mabs Directed Against The α5β1, αvβ3, αvβ5, Or α6β4 Integrins Antibody, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mabs directed against the α5β1, αvβ3, αvβ5, or α6β4 integrins antibody/product/Merck KGaA
    Average 90 stars, based on 1 article reviews
    mabs directed against the α5β1, αvβ3, αvβ5, or α6β4 integrins antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    R&D Systems recombinant human integrins used for surface plasmon resonance (spr) experiments (α6β4 and α6β1)
    SPR analysis of 41PB, 40PB and 5PB interactions with <t>α6β1</t> and α6β4 integrins. 41PB ( A , B ), 40PB ( C , D ) and 5PB ( E , F ) were added in two-fold dilution series to immobilised integrins. Results are shown in response units. ( G ) Kinetics of the interaction between the penton bases and integrins. Each interaction was measured four times. Variance is shown as ± SD.
    Recombinant Human Integrins Used For Surface Plasmon Resonance (Spr) Experiments (α6β4 And α6β1), supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human integrins used for surface plasmon resonance (spr) experiments (α6β4 and α6β1)/product/R&D Systems
    Average 90 stars, based on 1 article reviews
    recombinant human integrins used for surface plasmon resonance (spr) experiments (α6β4 and α6β1) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Merck KGaA α6β4 integrin mab1964 antibody
    MMP-8 expression alters <t>α6β4</t> subcellular distribution and myoepithelial cell morphology. a (i) Confocal images of β6-1089 cells transfected with empty vector ( EMPTY ) wild-type matrix metalloproteinase-8 ( MMP-8 WT ) or inactive mutant MMP-8 ( EA ) and grown on Fibronectin for 24 hours then fixed and co-stained for α6β4 ( red ) and plectin ( green ). Insert: cartoon illustrating hemidesmosome ( HD ) components, indicating the <t>integrin</t> α6β4 associates with plectin to link the complex to the keratin cytoskeleton. (ii) Co-localisation of α6β4 and plectin was determined by quantifying the number of yellow pixels per field of view in each condition then expressed as a ratio as compared to EMPTY. β6-1089 transfected with WT demonstrated a significant increase in α6β4 and plectin co-localisation, while the β6-1089 transfected with EA exhibited no change as compared to EMPTY. b (i) Confocal images of β6-1089 cells transfected with empty vector (EMPTY) wild-type MMP-8 (WT) or inactive mutant MMP-8 (EA) and grown on Fibronectin for 24 hours then fixed and co-stained for α6β4 ( green ) and phallodin ( red ). (ii) Morphological features of the transfected β6-1089 were analysed and length of trailing fibres was noted to be altered. Analysis of the length of these fibres indicated that β6-1089 transfected with MMP-8 WT significantly reduced the fibre length as compared to β6-1089 transfected with empty vector or MMP-8 EA. (iii) Analysis of the number of these fibres per cell also demonstrated a significant reduction in β6-1089 transfected with MMP-8 WT as compared to β6-1089 transfected with empty vector or MMP-8 EA. (iv) The final morphological alteration analysed was the physical space the cells occupied, the relative area occupied by β6-1089 transfected with MMP-8 WT was significantly larger than that occupied by β6-1089 transfected with empty vector or MMP-8 EA. c (i) Confocal images of N-1089 cells transfected with siRNA targeting MMP-8 ( siMMP-8 ) or Luciferase ( siLuc ) as a control grown on Fibronectin for 24 hours then fixed and co-stained for α6β4 ( green ) and phallodin ( red ). (ii) Trailing fibre length was significantly longer in N-1089 transfected with siMMP8 as compared to siLUC. (iii) There were significantly more trailing fibres per cell in the N-1089 + siMMP8 group as compared to N-1089 transfected with siLUC. * p = 0.05 ** p = 0.01, *** p = 0.001 (Student’s t test). Error bars = SEM, n = 3 independent experiments
    α6β4 Integrin Mab1964 Antibody, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/α6β4 integrin mab1964 antibody/product/Merck KGaA
    Average 90 stars, based on 1 article reviews
    α6β4 integrin mab1964 antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Blockade of Tat entry in IC-HUVEC by antibodies directed against the α5β1, αvβ3, and/or αvβ5 integrin. In ( A ), activated HUVEC were suspended and then incubated for 2 h with 5 μg/mL of monoclonal antibodies (mAb) directed against CD31 (upper left panel), α5β1 (upper right panel), or αvβ3 (lower left panel), or with anti-α5β1 and anti-αvβ3 mAb, combined together at 5 μg/mL each (lower right panel). In ( B ), IC-HUVEC were suspended and then incubated for 2 h with 5 μg/mL of anti-α6β4 mAb (upper left panel), or with 5 μg/mL of anti-αvβ5 mAb, alone (upper right panel) or combined with anti-α5β1 and anti-αvβ3 mAb (lower panel). For both ( A , B ), IC-HUVEC incubated with Ab dilution buffer (PBS-0.1% BSA) were employed as controls (Nil). After incubation, IC-HUVEC was exposed for 10 min to biologically active Tat (1–1000 ng/mL) or its buffer. Intracellular Tat content was assayed by intracellular staining and flow cytometry as described. Results are expressed as the percentage of positive cells as compared to isotype-stained samples and non-permeabilized cells. Box-plot data obtained from three to four independent experiments and analyzed by the Mann–Whitney test are shown. Dots indicate individual measures. Orange plots refer to IC-HUVEC incubated with the said mAbs; blue plots refer to control IC-HUVEC.

    Journal: International Journal of Molecular Sciences

    Article Title: HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication

    doi: 10.3390/ijms22010317

    Figure Lengend Snippet: Blockade of Tat entry in IC-HUVEC by antibodies directed against the α5β1, αvβ3, and/or αvβ5 integrin. In ( A ), activated HUVEC were suspended and then incubated for 2 h with 5 μg/mL of monoclonal antibodies (mAb) directed against CD31 (upper left panel), α5β1 (upper right panel), or αvβ3 (lower left panel), or with anti-α5β1 and anti-αvβ3 mAb, combined together at 5 μg/mL each (lower right panel). In ( B ), IC-HUVEC were suspended and then incubated for 2 h with 5 μg/mL of anti-α6β4 mAb (upper left panel), or with 5 μg/mL of anti-αvβ5 mAb, alone (upper right panel) or combined with anti-α5β1 and anti-αvβ3 mAb (lower panel). For both ( A , B ), IC-HUVEC incubated with Ab dilution buffer (PBS-0.1% BSA) were employed as controls (Nil). After incubation, IC-HUVEC was exposed for 10 min to biologically active Tat (1–1000 ng/mL) or its buffer. Intracellular Tat content was assayed by intracellular staining and flow cytometry as described. Results are expressed as the percentage of positive cells as compared to isotype-stained samples and non-permeabilized cells. Box-plot data obtained from three to four independent experiments and analyzed by the Mann–Whitney test are shown. Dots indicate individual measures. Orange plots refer to IC-HUVEC incubated with the said mAbs; blue plots refer to control IC-HUVEC.

    Article Snippet: MAbs directed against the α5β1, αvβ3, αvβ5, or α6β4 integrins were obtained from Chemicon-Merck-Millipore (Darmstadt, Germany).

    Techniques: Incubation, Bioprocessing, Staining, Flow Cytometry, MANN-WHITNEY, Control

    SPR analysis of 41PB, 40PB and 5PB interactions with α6β1 and α6β4 integrins. 41PB ( A , B ), 40PB ( C , D ) and 5PB ( E , F ) were added in two-fold dilution series to immobilised integrins. Results are shown in response units. ( G ) Kinetics of the interaction between the penton bases and integrins. Each interaction was measured four times. Variance is shown as ± SD.

    Journal: Scientific Reports

    Article Title: Enteric Species F Human Adenoviruses use Laminin-Binding Integrins as Co-Receptors for Infection of Ht-29 Cells

    doi: 10.1038/s41598-018-28255-7

    Figure Lengend Snippet: SPR analysis of 41PB, 40PB and 5PB interactions with α6β1 and α6β4 integrins. 41PB ( A , B ), 40PB ( C , D ) and 5PB ( E , F ) were added in two-fold dilution series to immobilised integrins. Results are shown in response units. ( G ) Kinetics of the interaction between the penton bases and integrins. Each interaction was measured four times. Variance is shown as ± SD.

    Article Snippet: Recombinant human integrins used for surface plasmon resonance (SPR) experiments (α6β4 and α6β1) were purchased from R&D Systems.

    Techniques:

    Examples of LDV-, RGD-, collagen- and laminin-binding integrins, their ligands and their presence/location in the small intestine.

    Journal: Scientific Reports

    Article Title: Enteric Species F Human Adenoviruses use Laminin-Binding Integrins as Co-Receptors for Infection of Ht-29 Cells

    doi: 10.1038/s41598-018-28255-7

    Figure Lengend Snippet: Examples of LDV-, RGD-, collagen- and laminin-binding integrins, their ligands and their presence/location in the small intestine.

    Article Snippet: Recombinant human integrins used for surface plasmon resonance (SPR) experiments (α6β4 and α6β1) were purchased from R&D Systems.

    Techniques:

    MMP-8 expression alters α6β4 subcellular distribution and myoepithelial cell morphology. a (i) Confocal images of β6-1089 cells transfected with empty vector ( EMPTY ) wild-type matrix metalloproteinase-8 ( MMP-8 WT ) or inactive mutant MMP-8 ( EA ) and grown on Fibronectin for 24 hours then fixed and co-stained for α6β4 ( red ) and plectin ( green ). Insert: cartoon illustrating hemidesmosome ( HD ) components, indicating the integrin α6β4 associates with plectin to link the complex to the keratin cytoskeleton. (ii) Co-localisation of α6β4 and plectin was determined by quantifying the number of yellow pixels per field of view in each condition then expressed as a ratio as compared to EMPTY. β6-1089 transfected with WT demonstrated a significant increase in α6β4 and plectin co-localisation, while the β6-1089 transfected with EA exhibited no change as compared to EMPTY. b (i) Confocal images of β6-1089 cells transfected with empty vector (EMPTY) wild-type MMP-8 (WT) or inactive mutant MMP-8 (EA) and grown on Fibronectin for 24 hours then fixed and co-stained for α6β4 ( green ) and phallodin ( red ). (ii) Morphological features of the transfected β6-1089 were analysed and length of trailing fibres was noted to be altered. Analysis of the length of these fibres indicated that β6-1089 transfected with MMP-8 WT significantly reduced the fibre length as compared to β6-1089 transfected with empty vector or MMP-8 EA. (iii) Analysis of the number of these fibres per cell also demonstrated a significant reduction in β6-1089 transfected with MMP-8 WT as compared to β6-1089 transfected with empty vector or MMP-8 EA. (iv) The final morphological alteration analysed was the physical space the cells occupied, the relative area occupied by β6-1089 transfected with MMP-8 WT was significantly larger than that occupied by β6-1089 transfected with empty vector or MMP-8 EA. c (i) Confocal images of N-1089 cells transfected with siRNA targeting MMP-8 ( siMMP-8 ) or Luciferase ( siLuc ) as a control grown on Fibronectin for 24 hours then fixed and co-stained for α6β4 ( green ) and phallodin ( red ). (ii) Trailing fibre length was significantly longer in N-1089 transfected with siMMP8 as compared to siLUC. (iii) There were significantly more trailing fibres per cell in the N-1089 + siMMP8 group as compared to N-1089 transfected with siLUC. * p = 0.05 ** p = 0.01, *** p = 0.001 (Student’s t test). Error bars = SEM, n = 3 independent experiments

    Journal: Breast Cancer Research : BCR

    Article Title: Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function

    doi: 10.1186/s13058-017-0822-9

    Figure Lengend Snippet: MMP-8 expression alters α6β4 subcellular distribution and myoepithelial cell morphology. a (i) Confocal images of β6-1089 cells transfected with empty vector ( EMPTY ) wild-type matrix metalloproteinase-8 ( MMP-8 WT ) or inactive mutant MMP-8 ( EA ) and grown on Fibronectin for 24 hours then fixed and co-stained for α6β4 ( red ) and plectin ( green ). Insert: cartoon illustrating hemidesmosome ( HD ) components, indicating the integrin α6β4 associates with plectin to link the complex to the keratin cytoskeleton. (ii) Co-localisation of α6β4 and plectin was determined by quantifying the number of yellow pixels per field of view in each condition then expressed as a ratio as compared to EMPTY. β6-1089 transfected with WT demonstrated a significant increase in α6β4 and plectin co-localisation, while the β6-1089 transfected with EA exhibited no change as compared to EMPTY. b (i) Confocal images of β6-1089 cells transfected with empty vector (EMPTY) wild-type MMP-8 (WT) or inactive mutant MMP-8 (EA) and grown on Fibronectin for 24 hours then fixed and co-stained for α6β4 ( green ) and phallodin ( red ). (ii) Morphological features of the transfected β6-1089 were analysed and length of trailing fibres was noted to be altered. Analysis of the length of these fibres indicated that β6-1089 transfected with MMP-8 WT significantly reduced the fibre length as compared to β6-1089 transfected with empty vector or MMP-8 EA. (iii) Analysis of the number of these fibres per cell also demonstrated a significant reduction in β6-1089 transfected with MMP-8 WT as compared to β6-1089 transfected with empty vector or MMP-8 EA. (iv) The final morphological alteration analysed was the physical space the cells occupied, the relative area occupied by β6-1089 transfected with MMP-8 WT was significantly larger than that occupied by β6-1089 transfected with empty vector or MMP-8 EA. c (i) Confocal images of N-1089 cells transfected with siRNA targeting MMP-8 ( siMMP-8 ) or Luciferase ( siLuc ) as a control grown on Fibronectin for 24 hours then fixed and co-stained for α6β4 ( green ) and phallodin ( red ). (ii) Trailing fibre length was significantly longer in N-1089 transfected with siMMP8 as compared to siLUC. (iii) There were significantly more trailing fibres per cell in the N-1089 + siMMP8 group as compared to N-1089 transfected with siLUC. * p = 0.05 ** p = 0.01, *** p = 0.001 (Student’s t test). Error bars = SEM, n = 3 independent experiments

    Article Snippet: Primary antibodies used were α6β4 integrin (Merck Millipore, Billerica, MA, USA, MAB1964) and plectin (Epitomics, Burlingame, CA, USA, 1399).

    Techniques: Expressing, Transfection, Plasmid Preparation, Mutagenesis, Staining, Luciferase, Control